Medication-induced acute kidney injury

Current Opinion in Critical Care

Volumn 22, Issue 6, 2016, Pages 542-545

  Goldstein, Stuart L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Drug combinations; Nephrotoxic medications

Indexed keywords

DRUG; BIOLOGICAL MARKER; CREATININE; PRESCRIPTION DRUG;

ACUTE KIDNEY FAILURE; DRUG INDUCED DISEASE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; NEPHROTOXICITY; REVIEW; BLOOD; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; COMPLICATION; DRUG EFFECTS; KIDNEY;

ACUTE KIDNEY INJURY; BIOMARKERS; CREATININE; HUMANS; KIDNEY; PRESCRIPTION DRUGS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84988624631     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000355     Document Type: Review

References (23)

1. Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 2011; 6:856-863.
2. Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care 2005; 11:555-565.
3. Zappitelli M, Moffett BS, Hyder A, Goldstein SL. Acute kidney injury in noncritically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 2011; 26:144-150.
4. Schaffzin JK, Dodd CN, Nguyen H, et al. Administrative data misclassifies and fails to identify nephrotoxin-associated acute kidney injury in hospitalized children. Hosp Pediatr 2014; 4:159-166.
5. Sutherland SM, Chawla LS, Kane-Gill SL, et al. 15 ADQI Consensus Group. Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus Conference. Can J Kidney Health Dis 2016; 3:11.
6. Rivosecchi RM, Kellum JA, Dasta JF, et al. Drug class combination-associated acute kidney injury: a review of the literature. Ann Pharmacother 2016. [Epub ahead of print]
7. Fournier JP, Sommet A, Durrieu G, et al. More on the 'Triple Whammy': antihypertensive drugs, nonsteroidal anti-inflammatory agents and acute kidney injury- A case/noncase study in the French pharmacovigilance database. Ren Fail 2014; 36:1166-1168.
8. Loboz KK, Shenfield GM. Drug combinations and impaired renal function-the 'triple whammy'. Br J Clin Pharmacol 2005; 59:239-243.
9. Camin RM, Cols M, Chevarria JL, et al. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: 'The Triple Whammy'. Nefrologia 2015; 35:197-206.
10. Goldstein SL, Kirkendall E, Nguyen H, et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 2013; 132:e756-e767.
11. Kirkendall ES, Spires WL, Mottes TA, et al. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm. Appl Clin Inform 2014; 5:313-333.
12. Misurac JM, Knoderer CA, Leiser JD, et al. Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr 2013; 162:1153-1159; 1159.e1.
13. Perazella MA. Drug use and nephrotoxicity in the intensive care unit. Kidney Int 2012; 81:1172-1178.
14. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294:813-818.
15. Taber SS, Mueller BA. Drug-associated renal dysfunction. Crit Care Clin 2006; 22:357-374; viii.
16. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005; 45:96-101.
17. Safina AI, Daminova MA, Abdullina GA. Acute kidney injury in neonatal intensive care: Medicines involved. Int J Risk Saf Med 2015; 27 (Suppl 1):S9-S10.
18. Goldstein SL, Mottes T, Simpson K, et al. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 2016; 90:212-221.
19. Chertow GM, Lee J, Kuperman GJ, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 2001; 286:2839-2844.
20. McCoy AB, Waitman LR, Gadd CS, et al. A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. Am J Kidney Dis 2010; 56: 832-841.
21. Huang JX, Blaskovich MA, Cooper MA. Cell-and biomarker-based assays for predicting nephrotoxicity. Expert Opin Drug Metab Toxicol 2014; 10:1621-1635.
22. Downes KJ, Dong M, Fukuda T, et al. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis. J Antimicrob Chemother 2016. [Epub ahead of print]
23. Mehta RL, Awdishu L, Davenport A, et al. Phenotype standardization for drug-induced kidney disease. Kidney Int 2015; 88:226-234.